Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats.
about
Effects of tempol and redox-cycling nitroxides in models of oxidative stress.Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidantsRedox control of vascular smooth muscle migration.Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempolVascular oxidative stress: the common link in hypertensive and diabetic vascular disease.Inhibition of apoptotic signaling and neointimal hyperplasia by tempol and nitric oxide synthase following vascular injury.Effect of a single, open-sea, air scuba dive on human micro- and macrovascular function.Crucial role of CD40 signaling in vascular wall cells in neointimal formation and vascular remodeling after vascular interventionsNox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migrationGenetic interleukin-10 deficiency causes vascular remodeling via the upregulation of Nox1.Therapeutic effects of water soluble danshen extracts on atherosclerosis.The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant ratsHeightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndromeTargeting the redox regulation of SERCA in vascular physiology and disease.Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage.High glucose oxidizes SERCA cysteine-674 and prevents inhibition by nitric oxide of smooth muscle cell migration.Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression.Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease.DJ-1/park7 protects against neointimal formation via the inhibition of vascular smooth muscle cell growth.
P2860
Q24595411-80F74514-411A-4000-943E-B9405476BE0FQ33572265-32E5947F-3973-477A-B378-0C336C1BECB6Q33690103-B1A688B1-E781-4113-910E-C12C65F155BDQ34149341-F9C6B87E-2DB6-44B6-BF5D-2DFFF9D28A5FQ34479731-CBB3513B-EC90-41FB-91F2-11CC7D7DA7FAQ34662166-2CC3C0A8-4F9A-4ABA-8AA4-7A2A316B000EQ34944826-B30C9BA0-7142-4435-B2B1-9A6E23973A3BQ35621648-7C5622DE-DBDE-49C7-9BF8-279347F02E4EQ35766044-6882E4DC-5A3B-4781-A7BC-C25B6E4364EFQ36027006-A650E966-D106-4883-AE0B-A980084080EEQ36582676-C738A5A7-30DC-4DEC-AC18-5EE7EBFAFB95Q36811716-E16981D8-E649-4304-83E7-0E03864CDADDQ37038730-2F4122FC-985D-4ED3-A874-4E04BFDE5F5FQ37666113-C070D6AD-FEA1-4003-8A77-D5D97A2BDC56Q38271210-72C9350C-8DC3-4D83-A75E-1EEB9014704DQ38605295-E5607F9F-876F-4028-8B2A-F8CB009F8EC1Q46937236-1CA43D8D-3C5D-412C-BEA8-34950FA32CDEQ50007964-32654F83-07B9-47BE-BA51-DE121526A8F7Q53350230-EE05A79B-317A-4B1A-A78C-74BA36E184A6
P2860
Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Tempol therapy attenuates medi ...... rotid artery of diabetic rats.
@en
Tempol therapy attenuates medi ...... rotid artery of diabetic rats.
@nl
type
label
Tempol therapy attenuates medi ...... rotid artery of diabetic rats.
@en
Tempol therapy attenuates medi ...... rotid artery of diabetic rats.
@nl
prefLabel
Tempol therapy attenuates medi ...... rotid artery of diabetic rats.
@en
Tempol therapy attenuates medi ...... rotid artery of diabetic rats.
@nl
P2093
P2860
P1476
Tempol therapy attenuates medi ...... rotid artery of diabetic rats.
@en
P2093
D K Jagadeesha
Francis Miller
Jason Deleon
Ram V Sharma
Ramesh C Bhalla
Timothy E Lindley
P2860
P304
P356
10.1152/AJPHEART.01071.2004
P577
2005-04-15T00:00:00Z